# Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

> **NCT05329090** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Hopital Foch** · enrollment: 75 (actual)

## Conditions studied

- IgA Vasculitis

## Interventions

- **DRUG:** Rituximab Injection
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05329090
- **Lead sponsor:** Hopital Foch
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-11
- **Primary completion:** 2025-07-16
- **Final completion:** 2026-01-16
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329090, "Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05329090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*